Stroke risk in women: The role of menopause and hormone therapy

The Lancet Neurology

Volumn 11, Issue 1, 2012, Pages 82-91

  Lisabeth, Lynda ^a   Bushnell, Cheryl ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CHLORMETHINE; CYCLOPHOSPHAMIDE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GESTAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IFOSFAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

AGE; AMENORRHEA; ATHEROSCLEROSIS; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CIGARETTE SMOKING; CYTOTOXICITY; DISEASE ASSOCIATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; ETHNICITY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INCIDENCE; MALNUTRITION; MENOPAUSE; MENSTRUATION; META ANALYSIS (TOPIC); MONOTHERAPY; MORTALITY; NONHUMAN; OBESITY; ONSET AGE; OOCYTE; OUTCOME ASSESSMENT; OVARY INFLAMMATION; OVARY INSUFFICIENCY; POSTMENOPAUSE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; STROKE; SUBARACHNOID HEMORRHAGE; SWEDEN; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; WOMEN'S HEALTH;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; RISK FACTORS; STROKE; WOMEN'S HEALTH;

EID: 83455249798     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70269-1     Document Type: Review

References (77)

1. Roger V, Go A, Lloyd-Jones D, et al. Heart Disease and Stroke Statistics 2011 Update: A report from the American Heart Association. Circulation 2010, 123:e18-e209.
2. Reeves MJ, Bushnell CD, Howard G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008, 7:915-926.
3. Roquer J, Rodriguez A, Gomis M Sex differences in first-ever acute stroke. Stroke 2003, 34:1581-1585.
4. Kapral MK, Fang J, Hill MD, et al. Sex differences in stroke care and outcomes. Results from the registry of the Canadian Stroke Network. Stroke 2005, 36:809-814.
5. Gargano J, Reeves M Sex differences in stroke recovery and stroke-specific quality of life. Stroke 2007, 38:2541-2548.
6. Gargano JW, Wehner S, Reeves MJ Sex differences in acute stroke care in a statewide stroke registry. Stroke 2008, 39:24-29.
7. Martínez-Sánchez P, Fuentes B, Fernández-Domínguez J, et al. Young Women Have Poorer Outcomes than Men after Stroke. Cerebrovasc Dis 2011, 31:455-463.
8. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005, 111:1242-1249.
9. Sutton-Tyrrell K, Lassila HC, Meilahn EN, Bunker C, Matthews KA, Kuller LH Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998, 29:1116-1121.
10. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA Gender differences in stroke incidence and poststroke disability in the Framingham Heart Study. Stroke 2009, 40:1032-1037.
11. Lofmark U, Hammarstrom A Evidence for age-dependent education-related differences in men and women with first-ever stroke. Results from a community-based incidence study in northern Sweden. Neuroepidemiology 2007, 28:135-141.
12. Lisabeth LD, Smith MA, Sanchez BN, Brown DL Ethnic disparities in stroke and hypertension among women: the BASIC project. Am J Hypertens 2008, 1:778-783.
13. Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005, 366:1773-1783.
14. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke 2004, 35:426-431.
15. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998, 147:259-268.
16. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996, 27:373-380.
17. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003, 74:317-321.
18. Vega T, Zurriaga O, Ramos JM, et al. Stroke in Spain: epidemiologic incidence and patterns; a health sentinel network study. J Stroke Cerebrovasc Dis 2009, 18:11-16.
19. Towfighi A, Saver J, Engelhardt R, Ovbiagele B A midlife stroke surge among women in the United States. Neurology 2007, 69:1898-1904.
20. Towfighi A, Markovic D, Ovbiagele B Persistent sex disparity in midlife stroke prevalence in the United States. Cerebrovasc Dis 2011, 31:322-328.
21. Ayala C, Croft J, Greenlund K, et al. Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke 2002, 33:1197-1201.
22. Towfighi A, Tai W, Markovic D, Ovbiagele B Sex-Specific Temporal Trends in In-Hospital Mortality After Stroke Among Middle-Age Individuals in the United States. Stroke 2011, 42:2740-2745.
23. Kapral M, Degani N, Hall R, et al. Gender differences in stroke care and outcomes in Ontario. Womens Health Issues 2011, 21:171-176.
24. Te Velde E, Pearson P The variability of female reproductive aging. Hum Reprod Update 2002, 8:141-154.
25. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995, 21:103-113.
26. McKinlay SM The normal menopause transition: an overview. Maturitas 1996, 23:137-145.
27. Liu Y, Ding J, Bush T, et al. Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidem 2001, 154:489-494.
28. Lee JS, Yaffe K, Lui LY, et al. Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch Neurol 2010, 67:195-201.
29. Selby C Sex hormone binding globuling: origin, function, and clinical significance. Ann Clin Biochem 1990, 27:532-541.
30. de Bruin J, Bovenhuis H, van Noord P, et al. The role of genetic factors in age at natural menopause. Hum Reprod 2001, 16:2014-2018.
31. Coulam C, Adamson S, Annegers J Incidence of premature ovarian failure. Obstet Gynecol 1986, 67:604-606.
32. De Vos M, Devroey P, Fauser P Primary ovarian insufficiency. Lancet 2010, 376:911-921.
33. Sybert V, McCauley E Turner's Syndrome. N Engl J Med 2004, 351:1227-1238.
34. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang Y-F Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001, 32:1104-1111.
35. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH Endogenous postmenopausal hormones and serum lipids: the Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab 2005, 90:1202-1209.
36. Wildman R, Colvin A, Powell L, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008, 15:414-421.
37. Harman S, Brinton E, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005, 8:3-12.
38. Matthews K, Crawford S, Chae C, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009, 54:2366-2373.
39. Rexrode KM, Manson JE, Lee I-M, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003, 108:1688-1693.
40. Maggio M, Ceda G, Lauretani F, et al. Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti Study. J Am Geriatr Soc 2009, 57:1810-1815.
41. Gillum LA, Mamidipudi SK, Johnston SC Ischemic stroke risk with oral contraceptives. A meta-analysis. JAMA 2000, 284:72-78.
42. Chan W-S, Ray J, Wai EK, et al. Risk of stroke in women exposed to low-dose oral contraceptives. A critical evaluation of the evidence. Arch Intern Med 2004, 164:741-747.
43. de Kleijn MJ, van der Schouw YT, Verbeek AL, Peeters PH, Banga JD, van der Graaf Y Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002, 155:339-345.
44. Jacobsen BK, Heuch I, Kvale G Age at natural menopause and stroke mortality: cohort study with 3561 stroke deaths during 37-year follow-up. Stroke 2004, 35:1548-1551.
45. Cooper GS, Sandler DP Age at natural menopause and mortality. Ann Epidemiol 1998, 8:229-235.
46. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005, 162:1089-1097.
47. Cui R, Iso H, Toyoshima H, et al. Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol 2006, 16:177-184.
48. Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999, 159:1061-1066.
49. Choi SH, Lee SM, Kim Y, Choi NK, Cho YJ, Park BJ Natural menopause and risk of stroke in elderly women. J Korean Med Sci 2005, 20:1053-1058.
50. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA Age at natural menopause and risk of ischemic stroke: the Framingham Heart Study. Stroke 2009, 40:1044-1049.
51. Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010, 17:506-510.
52. de Lecinana MA, Egido JA, Fernandez C, et al. Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007, 68:33-38.
53. Broer S, Eijkemans M, Scheffer G, et al. Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2001, 96:2532-2539.
54. Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006, 113:2425-2434.
55. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of Estrogen plus progestin on stroke in postmenopausal women. The Women's Health Initiative: A randomized trial. JAMA 2003, 289:2673-2684.
56. Bath PM, Gray LJ Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005, 330:342.
57. Sare GM, Gray LJ, Bath PM Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2008, 29:2031-2041.
58. Magliano DJ, Rogers SL, Abramson MJ, Tonkin AM Hormone therapy and cardiovascular disease: a systematic review and meta-analysis. BJOG 2006, 113:5-14.
59. LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011, 305:1305-1314.
60. Simon JA, Hsia J, Cauley JA, et al. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001, 103:638-642.
61. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI A clinical trial of estrogen-replacement therapy after ischemic stroke. NEJM 2001, 345:1243-1249.
62. Hemelaar M, van der Mooren M, Rad M, Kluft C, Kenemans P Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertil Steril 2008, 90:642-672.
63. Arana A, Varas C, Gonzalez-Perez A, Gutierrez L, Bjerrum L, Garcia Rodriguez LA Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause 2006, 13:730-736.
64. Renoux C, Dell'aniello S, Garbe E, Suissa S Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010, 340:c2519.
65. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000, 133:922-941.
66. Rosenfeld M, Kauser K, Martin-McNulty B, Polinsky P, Schwartz S, Rubanyi G Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 2002, 164:251-259.
67. Mendelsohn M, Karas R Molecular and cellular basis of cardiovascular gender differences. Science 2005, 308:1583-1587.
68. Rossouw J, Prentice R, Manson J, et al. postmenopausal hormone therapy and risk of cardiovascular disase by age and years since menopause. JAMA 2007, 297:1465-1477.
69. Weiner MB, Barnhart K, Xie D, Tannen RL Hormone therapy and coronary heart disease in young women. Menopause 2008, 15:86-93.
70. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. Writing Group for the Women's Health Initiative Investigators.
71. Carcaillon L, Alhenc-Gelas M, Bejot Y, et al. Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly. The Three-City Cohort Study. Arterio Thromb Vasc Biol 2011, 31:1445-1451.
72. Kolominsky-Rabas P, Weber M, Gefeller O, Neundoerfer B, Heuschmann P Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study. Stroke 2001, 32:2735-2740.
73. Mosca L, Benjamin E, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women 2011 update: A guideline from the American Heart Association. Circulation 2011, 123:1243-1262.
74. Goldstein L, Bushnell C, Adams R, et al. Guidelines for the primary prevention of stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010, 42:517-584.
75. Furie K, Kasner S, Adams R, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:227-276.
76. Schenck-Gustafsson K, Brincat M, Erel C, et al. EMAS position statement: Managing menopause in the context of coronary heart disease. Maturitas 2011, 68:94-97.
77. Lloyd-Jones D, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010, 121:586-613.